✓ Last verified: February 21, 2026 — Edited & verified by Angelica Bottaro for HealingMaps Editorial Staff
Known For: The only academic medical center offering ketamine-based treatment in the Cincinnati region — one of 22 National Network of Depression Centers sites in the US. Provides access to 25+ clinical trials and offers both intranasal ketamine AND Spravato protocols.
| Review Scores | Academic institution reputation; patients value access to cutting-edge research and clinical trials |
| Location | Cincinnati, OH |
| Address | 260 Stetson St, Suite 3200, Cincinnati, OH 45219 |
| Phone | (513) 585-6663 |
| Website | uchealth.com |
| Treatments | Intranasal Esketamine (Spravato), Intranasal Ketamine, TMS, ECT, Medication Management, Psychotherapy, Clinical Trials |
| Conditions Treated | Treatment-Resistant Depression, MDD, Mood Disorders, Substance Use Disorders |
| Cost | Academic medical center billing; contact for insurance details |
| Insurance | Accepts most major insurance plans through UCHealth billing |
| Clinical Lead | UC Gardner Neuroscience Institute team — 20+ physicians and staff in behavioral medicine, neuroscience, and neuroendocrinology |
💡 No clinic-specific pricing posted? See our ketamine therapy cost guide for typical pricing ranges by treatment type and insurance pathways.
HealingMaps Take: UCHealth Mood Disorders Center is the institutional heavyweight in Cincinnati’s ketamine landscape. Affiliated with the University of Cincinnati College of Medicine and designated as one of only 22 National Network of Depression Centers academic sites in the United States, this is not a boutique infusion clinic — it is a research hospital providing ketamine-based treatment within the most rigorous clinical framework available. The center offers both intranasal Spravato (the FDA-approved esketamine) and a separate intranasal ketamine protocol — having both allows clinicians to match the intervention to the patient rather than offering a one-size-fits-all approach. With 25+ ongoing clinical trials, patients here may have access to experimental protocols and next-generation treatments that no private clinic can offer. The team of 20+ physicians and staff spans behavioral medicine, neuroscience, neuroendocrinology, cognition, and addiction — a depth of expertise that means complex, multi-diagnosis patients get seen by specialists who understand the full picture. Insurance acceptance through UCHealth’s hospital billing system is broader than most private ketamine clinics. The trade-off is the academic medical center experience: appointments may take longer to schedule, the environment is clinical rather than spa-like, and the bureaucracy of a large health system can be frustrating. But for patients with complex presentations or those who want the highest level of clinical oversight, this is the gold standard in the region.
Market Position: UCHealth Mood Disorders Center is a Spravato-certified clinic in the Cincinnati metro. Spravato (esketamine) is the FDA-approved ketamine treatment that most commercial insurance plans cover after prior authorization — unlike cash-pay IV ketamine.
Industry pricing reference. UCHealth Mood Disorders Center has not published specific per-session pricing — contact the clinic directly for a quote. The calculator above shows typical metro-level cost estimates across protocols, not this clinic’s specific prices.
| Protocol | Typical Industry Cost | Offered Here |
|---|---|---|
| IV Ketamine | $350–$650/session | — |
| Spravato (esketamine) | $0–$250 copay (insured) | ✓ Yes |
| IM Ketamine | $250–$400/injection | — |
| KAP (with therapist) | $400–$1,200/session | — |
| At-home troches | $150–$300/month | — |
This 2-question summary is matched to the protocols and conditions UCHealth Mood Disorders Center treats. Editorial responses are HealingMaps-authored, grounded in our 2026 Ketamine Clinic Intelligence Report.
Yes — UCHealth Mood Disorders Center offers Spravato, which means they’re FDA REMS-certified and maintain the required two-hour in-office monitoring window after each dose. Spravato is the primary insurance-covered ketamine option for treatment-resistant depression. Worth confirming the prior-authorization timeline before booking your first session.
UCHealth Mood Disorders Center treats depression via Spravato (FDA-approved for TRD). The Spravato pathway is the most likely to obtain commercial insurance coverage. TRD is typically defined as two or more prior antidepressant trials without sufficient response — patients meeting that bar are best candidates here.
Leave a Reply